EUVIMEDOpdag EUVIMED
Crossref

Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury

Haiying Zhu, Jie Cen, Chenggang Hong, Haiyang Wang, Yuanmei Wen, Qiaojun He, Yongping Yu iD, Ji Cao, Wenteng Chen iD

ACS Chemical Biology · 2023-06-16 · 18 (6) · 1294-1304

DOI: 10.1021/acschembio.2c00914 ↗

At a glance

Journal article in ACS Chemical Biology, published online on 2023-05-12. Written by Haiying Zhu and 8 co-authors. Institution: Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang…. Major MEDLINE topics: Ferroptosis, Acute Kidney Injury, Rhabdomyolysis. Cited 25 times so far (Crossref); 41 references. Funded by: Basic Public Welfare Research Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Acute kidney injury (AKI) is a global health problem that occurs in a variety of clinical settings. Despite some advances in supportive clinical care, no medicinal intervention has been demonstrated to reliably prevent AKI thus far. Therefore, it is highly necessary to investigate the pathophysiology and mechanisms involved in AKI for the discovery of therapeutics. In the current study, a robust change in the level of renal malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) and elevated renal iron levels were observed in murine rhabdomyolysis-induced AKI (RM-AKI), which supports a pathogenic role of labile iron-mediated ferroptosis and provides a chance to utilize iron chelation for RM-AKI prevention. Given that the existing small molecule-based iron chelators did not show promising preventative effects against RM-AKI, we further designed and synthesized a new hydroxypyridinone-based iron chelator to potently inhibit labile iron-mediated ferroptosis. Lead compound AKI-02 was identified, which remarkably protected renal proximal tubular epithelial cells from ferroptosis as well as showed excellent iron chelation ability. Moreover, administration of AKI-02 led to renal function recovery, a result that was substantiated by the decreased contents of BUN and creatinine, as well as the reduced labile iron level and improved histopathology. Thus, our studies highlighted that targeting labile iron-mediated ferroptosis could provide therapeutic benefits against RM-AKI.

Subjects

MeSH terms (MEDLINE)

FerroptosisAcute Kidney InjuryRhabdomyolysisHumansMiceAnimalsIronIron Chelating Agents

Substances

IronIron Chelating Agents

Authors and institutions

  • Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310058, China.
  • Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou 310058, China.
  • Cancer Center, Zhejiang University, Hangzhou 310058, China.

ORCID profiles: Yongping Yu, Wenteng Chen

Funding

  • Basic Public Welfare Research Program of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province

Cite

APA

Zhu, H., Cen, J., Hong, C., Wang, H., Wen, Y., He, Q., Yu, Y., Cao, J., & Chen, W. (2023). Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury. ACS Chemical Biology, 18(6), 1294-1304. https://doi.org/10.1021/acschembio.2c00914

Vancouver

Zhu H, Cen J, Hong C, Wang H, Wen Y, He Q, et al. Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury. ACS Chemical Biology. 2023;18(6):1294-1304. doi:10.1021/acschembio.2c00914

BibTeX
@article{Zhu2023,
  author = {Zhu, Haiying and Cen, Jie and Hong, Chenggang and Wang, Haiyang and Wen, Yuanmei and He, Qiaojun and Yu, Yongping and Cao, Ji and Chen, Wenteng},
  title = {Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury},
  journal = {ACS Chemical Biology},
  year = {2023},
  volume = {18},
  number = {6},
  pages = {1294--1304},
  doi = {10.1021/acschembio.2c00914}
}
Start for free →